| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.7M | — |
| R&D Expense | $46.4M | +9.3% |
| SG&A Expense | $98.4M | +26.6% |
| Operating Income | -$109.7M | +24.4% |
| Interest Expense | $0 | — |
| Pre-tax Income | $12.9M | +109.2% |
| Income Tax | $2.0M | — |
| Net Income | $10.9M | +107.8% |
| EPS (Basic) | $0.40 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $358.3M | +121.3% |
| Accounts Receivable | $42.0M | — |
| Inventory | $7.0M | — |
| Current Assets | $587.9M | +53.2% |
| Total Assets | $818.4M | +46.5% |
| Current Liabilities | $33.1M | +14.7% |
| Total Liabilities | $39.7M | +9.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.8M | +11.7% |
| Capital Expenditures | $11.8M | -77.7% |
| Investing Cash Flow | $82.6M | +172.4% |
| Financing Cash Flow | $202.8M | +473.6% |
| Free Cash Flow | -$100.6M | +34.5% |
| +107.3% |
| EPS (Diluted) | $0.39 | +107.1% |
| Stockholders' Equity |
| $778.6M |
| +49.1% |